Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

KDDI selects Ericsson cloud-native dual-mode 5G Core

· Ericsson to deploy cloud-native, dual-mode 5G Core, enabling the launch of 5G Standalone services in KDDI's network · Deployment will enable KDDI to develop new 5G use cases for consumers, enterprises and industry partners · Zero-touch operation, including continuous delivery and integration processes (CI/CD), is enhanced based on the container-based microservice architecture and automation capabilitiesEricsson (NASDAQ: ERIC) has been selected by KDDI to deploy cloud-native dual-mode 5G Core in its 5G Standalone network in Japan, paving the way to ramp-up 5G use case development and

Initiator Pharma announces last day of trading in warrants of series TO 2

The exercise period for warrants of series TO 2 (“TO 2”), which were issued in connection with Initiator Pharma A/S's (“Initiator Pharma” or “the Company”) rights issue and directed issue of units in June 2020, runs until the 15[th] of December 2020. The last day of trading in TO 2 is tomorrow, Friday the 11[th] of December 2020. Holders of TO 2 have the right to, for each warrant, subscribe for one new share in Initiator Pharma at a price of SEK 4.90. Upon full exercise of all warrants, Initiator Pharma will receive approximatelySEK 16.4 million before issue costs – capital that will be

Alligator Bioscience launches ALLIGATOR-FAB™ – a novel human antibody library

Lund, Sweden, December 10, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of a novel proprietary human synthetic antibody library in Fab (Fragment antigen-binding) format – ALLIGATOR-FAB™. The design of the library and antibody diversity has been optimized to ensure the development of highly functional antibodies with excellent developability properties. The ALLIGATOR-FAB library is built on multiple antibody backbones with optimal drug development properties to further increase the structural diversity of generated antibodies. The ALLIGATOR-FAB

Mandatory notification of trade

On December 9[th] 2020, DNB has, on behalf of Otello Corporation, purchased 8,421 shares for use in the group's employee share purchase plan (ESPP). The shares have been acquired at a price of NOK 21,24. The discounted share price to the employees is NOK 16,99 per share. Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i) AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their businesses, capitalizing

SAVINGS PROGRAMME FOR EMPLOYEES

Reference is made to the stock exchange announcement of 14 March 2019 regarding the introduction of a share saving programme for employees in SpareBank 1 SR-Bank. The purpose of the programme is to motivate employees to become co-owners of the bank and at the same time to enhance interest in the bank’s strategy and results. The Board of Directors of SpareBank 1 SR-Bank have decided to continue the scheme in 2021. Employees are invited to save a fixed amount per month to buy shares in the bank. Employees who register for the savings programme can choose to purchasing shares amounting to NOK

Inhalation Sciences appoints new Chief Commercial Officer to drive global sales

Inhalation Sciences (ISAB) has appointed Paolo Raffaelli as its new Chief Commercial Officer (CCO). Mr Raffaelli has extensive experience driving international sales in a wide range of medical device companies and takes up his position on December 14, 2020.The new CCO will be responsible for driving ISAB sales in Europe, the US and other international markets. He will have overall responsibility for Sales and Marketing activities, with a primary focus on account targeting.Paolo Raffaelli has over 20 years’ executive experience in the life science and medical device industry, with

EQT Infrastructure acquires Molslinjen, Denmark’s largest passenger ferry company

· EQT Infrastructure acquires Molslinjen, a critical part of Denmark’s domestic transport network, linking major population centers and creating connectivity between regions as well as connecting several important islands to the mainland · Molslinjen contributes to increased economic activity and social development as an enabler of movement of passengers and goods across its network of “floating bridges” · EQT Infrastructure will support Molslinjen’s continued sustainability agenda through investments in the decarbonization of the ferry fleet and the acceleration of the transition

Bio-Works signs distribution agreement with Yong Chien Technology Inc. in Taiwan

Bio-Works Technologies (Nasdaq First North) has signed a Distribution Agreement with Taipei-based Yong Chien Technology Inc. The agreement covers import, storage, distribution, marketing promotion and sales of WorkBeads resins and pre-packed BabyBio and OptioBio columns in Taiwan.Bio-Works  is strengthening its presence in Taiwan by engaging a well-respected local distributor with years of experience of supplying downstream bioprocessing solutions to academia, research institutes and the growing domestic biotech, biosimilar and biopharma industry. Bio-Works

Presentations at ESMO Immuno-Oncology Virtual Congress build case for CLEVER-1 as a new immune checkpoint target

Data from ongoing PhI/II MATINS trial showcasedRole of myeloid cells in shaping the tumour microenvironment highlightedCompany announcement, 10 December 2020 at 9.00 AM (EET)TURKU – FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today announces that two presentations at the European Society of Medical Oncology (ESMO) Immuno-Oncology Virtual Congress 2020 will showcase data from the Company’s PhI/II MATINS study and explore the role of myeloid cells in shaping the tumour microenvironment (TME). ‘CLEVER-1 a new immune

Calliditas wins the 2020 SwedenBio Award

The winner of this year’s SwedenBIO Award was announced on Wednesday December 9[th]. Calliditas Therapeutics AB (publ) (“Calliditas”) received the award in recognition of its successful clinical development program of Nefecon, which culminated in the recent positive topline data readout of the pivotal Phase 3 NefIgArd trial.SwedenBio annually awards this prize to a company which has excelled in terms of R&D, business development and growth whilst contributing to societal benefit. “This year’s winner has shown impressive professionalism and staying power with regards to the development of

Directorate Change

Directorate Changes10 December 2020  EnQuest PLC ('EnQuest') announces that Laurie Fitch, Non-Executive Director, has decided to step down upon expiry of her service agreement on 8 January 2021.   Martin Houston, Chairman of EnQuest: "I would like to thank Laurie most sincerely on behalf of the Board for her valuable contribution during her time with EnQuest. In particular, her work with the Employee Forum and on the broad ESG agenda across the company has been extremely helpful. She will be missed and I wish her all the best for her future endeavours."  This announcement

The Ocean Cleanup prepares for series production of Interceptor - partners with Konecranes

Enabling The Ocean Cleanup to scale up and tackle the world’s 1000 most polluting riversThe Ocean Cleanup, the Dutch non-profit developing advanced technologies to rid the oceans of plastic, and Konecranes, a world-leading group of Lifting Businesses™, announced today a partnership to design, manufacture, and service The Ocean Cleanup’s Interceptor™, which is designed to extract plastic from rivers before entering the ocean. This is an important step as the non-profit organization prepares to tackle the world’s 1000 most polluting rivers.Deploying Interceptors on a large scale is

New Pexip Private Cloud Meets Growing Demand for Increased Video Conferencing Security Combined with Ease of Deployment and Scale

Provides the missing rung between self-hosted and shared cloud video conference deployment options, delivering scalable and secure enterprise-grade infrastructure without the burden of day-to-day management ·Beta customer trials show the new service can speed up time-to-deployment by a factor of 10X and reduce managed IT overheads by an estimated 60-80% · Addresses the growing needs of medium to large enterprises and particularly suited to sectors with stringent data control and privacy requirements10th December 2020 - Pexip, a leading provider of enterprise video conferencing

Swedish property portal Hemnet once again ranked most popular in the world according to new report

A new ranking of the 50 largest property portals shows Hemnet once again as the most popular in the world, highlighting the continued interest that Swedes have towards their homes and the property market. During September, Hemnet had 22 million visits, or 2222 visits per ‘000 population, according to data from the website analytics tool Similarweb which has been compiled by the industry analyst AIM Group. Hemnet tops the list of the world's most popular property portals. Dutch portal Funda comes in second followed by Australian Realestate.com.au. AIM:s ranking does not include app

IRRAS Announces Expansion of IRRAflow Launch to Latin America

· Finalization of agreement with distribution partner in Argentina allows access into initial Latin American markets · Anade SA is a well-established partner with deep existing relationships in neurosurgical spaceStockholm, December 10, 2020 – IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced an exclusive distribution agreement with Anade SA, a well-established distributor of leading neurosurgical medical devices and technologies through Latin America. “We are pleased to partner with

Realising opportunities for future growth and financial update: Sobi Capital Markets Day 2020

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI ) is hosting a virtual Capital Markets Day today. Presentations from senior management will showcase Sobi’s strategy for growth in the core areas of Immunology and Haematology, strengthening its pipeline, extending its geographical footprint and expanding growth opportunities. New peak sales expectations for key products as well as revenue ambition for 2025 are communicated.   “Sobi has been through a significant transformation in the past few years and we are now well positioned for the next phase,” says Guido

Realheart's CEO invited to speak at EUMS

The European Mechanical Circulatory Support Summit is one of the world's largest medical congresses in heart pumps. This year, Realheart's CEO Azad Najar was invited to talk about the company's artificial heart and the research that is being conducted.The European Mechanical Circulatory Support Summit brings together the world elite in heart pump surgery, both industry representatives and researchers. This fifteenth congress took place digitally during five days from 30 November to 4 December. Azad Najar, CEO of Realheart, was contacted by the Congress' Scientific Committee with an

Systemair AB Interim Report Q2 2020/21

Press Release, December 10, 2020 Second quarter, August – October 2020 · Net sales decreased 11.1 percent, to SEK 2,207 million (2,483). · Organic growth was -3.8 percent (+6.0). · Operating profit (EBIT) amounted to SEK 214 million (284), including a goodwill impairment charge of SEK -11 million. · The operating margin was 9.7 percent (11.4). · Profit after tax amounted to SEK 141 million (194). · Earnings per share totalled SEK 2.70 (3.72). · Cash flow from operating activities amounted to SEK 285 million (297). Roland Kasper, President and CEO, comments:“

Veidekke ASA: Construction job at the proton centre in Bergen

Veidekke has been commissioned by Helse Bergen HF to carry out the groundworks for the new proton centre at Haukeland University Hospital in Bergen. The contract is a design and build contract with a value of NOK 116 million, excluding VAT.Veidekke will prepare the site for the new building, which entails demolishing an existing parking facility, securing the rock face behind the building and blasting a 650 metres tunnel and 60 metres lift shaft to the central building to link the proton centre to the rest of the hospital. The new proton centre will be located in Haukelandsbakken, just

SOTKAMO SILVER AB: PUBLICATION OF THE REVISED STRATEGY

Press release: Stockholm, December 10, 2020 07:45 CETSotkamo Silver AB will announce its revised strategy for 2021-2025 today, December 10, 2020, at 10:00 am Finnish time in a virtual event. The Group's revised strategy, presented in the event, is based on the responsibility and support to the local development. The event will be held in Finnish and the material presented will be in English. The presentation will be available at approximately 09:45 Finnish time on the company's website at: https://www.silver.fi/en/investors/presentations Stockholm, December 10, 2020 Sotkamo

STOREBRAND ASA: Capital Markets Day today at 14:00 CET

STRATEGY 2021-2023: LEADING THE WAY IN SUSTAINABLE VALUE CREATIONStorebrand is hosting a virtual Capital Markets Day today at 14:00 CET, outlining the Group strategic plan for 2021-2023 'Leading the Way in Sustainable Value Creation'. The presentation includes dedicated sessions on occupational pensions, asset management, retail and cash and capital.   – Storebrand has followed an active and consistent strategy with a proven track record of shifting the business mix towards capital light savings and insurance products, replacing legacy guaranteed business. The Storebrand of the future

Social media provides small and medium-sized firms (SMEs) with tools to mitigate internationalisation-related threats

For SMEs seeking to enter the international markets, social media is a tool for overcoming liabilities connected to their smallness, newness and foreignness, a new study from the University of Eastern Finland shows. According to the study, SMEs use social media to become embedded within various strategic and emerging international networks they deem important for their operations. “Companies seeking to go global are often unsure about how to best use social media and international networks to tackle any obstacles standing between them and the international markets. Our findings can help

Investing for a Sustainable Future: Swedish Space Corporation (SSC) invests in exciting new UK/Swedish start-up “GlobalTrust”

SSC is pleased to announce investment in a new start-up data analytics business with offices in the UK and Sweden to address some of the most crucial environmental and social issues of the time. GlobalTrust will focus on supporting public policy and corporate social responsibility imperatives that are aligned with societies’ expectations and working towards a better and more sustainable planet. This initiative is being led by SSC and is supported by the UK’s Satellite Applications Catapult – a government established not-for-profit company with its core mandate focused on promoting and

Targovax to present at DNB’s 11[th] Annual Nordic Healthcare Conference

Oslo, 10 December 2020 – Targovax ASA, announces that Øystein Soug, CEO of Targovax, will present the company at DNB’s 11[th] Annual Nordic Healthcare Conference, Tuesday 15 December.DNB’s 11[th] Annual Nordic Healthcare ConferenceDate: 15 December 2020Presenter: Øystein Soug, CEOPresentation time: 12:30 CETThe presentation will be available to download at www.targovax.com  after the event.

There are no items matching the current filter
There are no more items matching the current filter
Back to top